Target intelligence / Profile preview

Monoamine neurotransmitter synthesis pathways

Molecular classification
Enzyme, Metabolic pathway
01

Overview

The serotonin, norepinephrine, and dopamine synthesis pathways are the metabolic routes responsible for the production of monoamine neurotransmitters from amino acid precursors. Serotonin is synthesized from tryptophan via tryptophan hydroxylase (TPH) and aromatic L-amino acid decarboxylase (AADC) (StatPearls: Physiology, Neurotransmitters, 2023). Norepinephrine and dopamine are synthesized from tyrosine via tyrosine hydroxylase (TH), AADC, and dopamine beta-hydroxylase (DBH) (PubChem: Tyrosine Hydroxylase, 2024). These pathways are critical for regulating mood, motor control, and autonomic functions. Dysregulation is linked to Parkinson's disease, depression, and ADHD (NIH: Parkinson's Disease: Challenges, Progress, and Promise, 2023). Drugs like Levodopa act as precursors to bypass rate-limiting steps, while others like Metyrosine inhibit synthesis to treat specific conditions (StatPearls: Tyrosine Hydroxylase, 2023). These pathways represent a complex network of enzymatic reactions that maintain chemical homeostasis in the brain and periphery.

Other names
Biogenic amine synthesisCatecholamine and indoleamine synthesisSerotonin and catecholamine biosynthesis
02

Mechanism of action

Modulation of neurotransmitter levels by providing metabolic precursors or inhibiting rate-limiting enzymes within the biosynthetic pathways.

03

Biological functions

Neurotransmitter biosynthesisSignal transductionMetabolismHomeostasis
04

Disease associations

Parkinson's diseaseDepressionAnxiety disordersAttention deficit hyperactivity disorder (ADHD)SchizophreniaBipolar disorderPheochromocytoma
05

Safety considerations

Serotonin syndromeDopamine dysregulation syndromeOrthostatic hypotensionPsychosisDyskinesia
06

Interacting drugs

Levodopa

5 more in the full profile.

07

Biomarkers

Cerebrospinal fluid 5-hydroxyindoleacetic acid (5-HIAA)Cerebrospinal fluid homovanillic acid (HVA)Plasma metanephrinesUrinary vanillylmandelic acid (VMA)

Beyond the preview

Go deeper on Monoamine neurotransmitter synthesis pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Monoamine neurotransmitter synthesis pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call